LINC02392

Across TCGA pan-cancer cohorts, LINC02392 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02392 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC02392 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02392 expression acts as an unfavorable survival marker, although some lineages such as ESCA and CHOL show a favorable association.

HNSC, ACC, and KICH are the cancer types where LINC02392 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.313	0.466	<.001	90	view →
ACC	OS	Tertile	III,IV	0.272	0.650	.002	58	view →
KICH	OS	Tertile	All	0.530	0.954	<.001	51	view →
PAAD	OS	Tertile	All	0.241	0.448	.002	39	view →
LIHC	DFS	Tertile	All	0.187	0.561	<.001	36	view →
ESCA	OS	Median	III,IV	0.615	0.327	.007	34	view →
KIRC	DFS	Tertile	II,III,IV	0.517	0.705	.015	32	view →
BRCA	OS	Quartile	III,IV	0.361	0.589	.010	29	view →
CHOL	DFS	Tertile	II,III,IV	1.000	0.133	.010	27	view →
UVM	OS	Tertile	III,IV	0.220	0.811	.021	18	view →
GBM	OS	Median	All	0.325	0.487	.004	12	view →
TGCT	DFS	Tertile	All	0.712	0.857	.039	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02392–HNSC (OS)

Open the HNSC breakdown →